Reaktionsgleichung
Br[C:2]1[CH:9]=[N:8][CH:7]=[C:6]([Br:10])[C:3]=1[CH:4]=[O:5].[C:11]1(=[O:24])[C:16]2[S:17][C:18]3[CH2:23][CH2:22][CH2:21][CH2:20][C:19]=3[C:15]=2[CH2:14][CH2:13][NH:12]1.C(=O)([O-])[O-].[Cs+].[Cs+].CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].O1CCOCC1>[Br:10][C:6]1[CH:7]=[N:8][CH:9]=[C:2]([N:12]2[C:11](=[O:24])[C:16]3[S:17][C:18]4[CH2:23][CH2:22][CH2:21][CH2:20][C:19]=4[C:15]=3[CH2:14][CH2:13]2)[C:3]=1[CH:4]=[O:5]Komponenten
7
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Reaktionsbedingungen
- Temperatur
- 100 °C
Versuchsvorschrift
To a 100-mL single-neck round-bottomed flask equipped with a magnetic stirrer and reflux condenser was charged with 1,4-dioxane (15 mL), 3,5-dibromoisonicotin-aldehyde (400 mg, 1.5 mmol), 8-thia-5-azatricyclo[7.4.0.02,7]trideca-1(9),2(7)-dien-6-one 105e (146 mg, 0.76 mmol), and cesium carbonate (176 mg, 1.5 mmol). Xantphos (40 mg, 0.08 mmol) and Pd2(dba)3 (70 mg, 0.08 mmol) were added, and the reaction mixture was heated at 100° C. for 5 h. After this time the reaction was cooled to room temperature and filtered. The filtrate was concentrated under reduced pressure and the residue was purified on flash column eluting with DCM:MeOH (20:1) to afford 105f (200 mg, 70%). MS: [M+H]+ 377.
Aufarbeitung
- customTo a 100-mL single-neck round-bottomed flask equipped with a magnetic stirrer
- temperaturereflux condenser
- temperatureAfter this time the reaction was cooled to room temperature
- filtrationfiltered
- concentrationThe filtrate was concentrated under reduced pressure
- customthe residue was purified on flash column
- washeluting with DCM:MeOH (20:1)
Quellen und Nachweise
- ORD-Eintrag
- ord-819c52c380a8494b82abdc61d2b83226
- Quelldatensatz
- uspto-grants-2014_05
- Patentnummer
- US08716274B2
Verknüpfte Notizen
Wird geladen…